Chemeca Drugs Private Limited

Manufacturer of active pharmaceutical ingredients and intermediates established in 2008, with a plant in J.N. Pharma City at Parawada, Anakapalli district. Its commercial portfolio includes sertraline, diltiazem, carisoprodol, bupropion, clopidogrel, fexofenadine, pirfenidone, quetiapine fumarate and celecoxib. Under development are tolvaptan, rifaximin, empagliflozin, dapagliflozin, finerenone and rivaroxaban. It cleared a US FDA inspection in 2023.